Charles Schwab
PRAH

Charles Schwab’s PRA Health Sciences, Inc. PRAH Stock Holding History

Charles Schwab’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-322,370
Closed -$53.3M – 3602
2021
Q2 		$53.3M Sell
322,370
-49,839
-13% -$8.32M 0.02% 817
2021
Q1 		$57.1M Buy
372,209
+4,953
+1% +$673K 0.02% 745
2020
Q4 		$46.1M Buy
367,256
+7,451
+2% +$833K 0.02% 812
2020
Q3 		$36.5M Buy
359,805
+5,217
+1% +$532K 0.02% 834
2020
Q2 		$34.5M Sell
354,588
-2,665
-0.7% -$248K 0.02% 807
2020
Q1 		$29.7M Buy
357,253
+19,017
+6% +$1.85M 0.02% 746
2019
Q4 		$37.6M Buy
338,236
+1,225
+0.4% +$126K 0.02% 802
2019
Q3 		$33.4M Sell
337,011
-46,558
-12% -$4.62M 0.02% 828
2019
Q2 		$38M Buy
383,569
+95,632
+33% +$9.13M 0.02% 721
2019
Q1 		$31.8M Buy
287,937
+8,776
+3% +$917K 0.02% 831
2018
Q4 		$25.7M Sell
279,161
-3,417
-1% -$346K 0.02% 827
2018
Q3 		$31.1M Sell
282,578
-52,637
-16% -$5.48M 0.02% 830
2018
Q2 		$31.3M Sell
335,215
-92,300
-22% -$7.95M 0.02% 752
2018
Q1 		$35.5M Sell
427,515
-38,491
-8% -$3.42M 0.03% 648
2017
Q4 		$42.4M Buy
466,006
+91,181
+24% +$7.58M 0.03% 530
2017
Q3 		$28.6M Buy
374,825
+139,895
+60% +$10.6M 0.02% 671
2017
Q2 		$17.6M Buy
234,930
+22,303
+10% +$1.55M 0.02% 954
2017
Q1 		$13.9M Buy
212,627
+77,057
+57% +$4.54M 0.01% 1071
2016
Q4 		$7.47M Buy
135,570
+27,567
+26% +$1.51M 0.01% 1467
2016
Q3 		$6.1M Buy
108,003
+5,054
+5% +$248K 0.01% 1515
2016
Q2 		$4.3M Buy
102,949
+22,937
+29% +$1.06M 0.01% 1666
2016
Q1 		$3.42M Buy
80,012
+17,247
+27% +$729K ﹤0.01% 1746
2015
Q4 		$2.84M Buy
62,765
+1,868
+3% +$78.5K ﹤0.01% 1887
2015
Q3 		$2.37M Buy
60,897
+12,291
+25% +$492K ﹤0.01% 1972
2015
Q2 		$1.77M Buy
48,606
+1,394
+3% +$44.1K ﹤0.01% 2163
2015
Q1 		$1.36M Buy
47,212
+6,772
+17% +$189K ﹤0.01% 2254
2014
Q4 		$980K Buy
+40,440
New +$911K ﹤0.01% 2358

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Charles Schwab's PRAH Position: Q3 2021 in Review

Charles Schwab sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 322,370 shares — an estimated $53.3M sold.

Charles Schwab first reported a position in PRAH in Q4 2014 and held it in 27 quarters. The position peaked at $57.1M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Charles Schwab reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Charles Schwab sold 322,370 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $53.3M.
  • Charles Schwab first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 27 quarters.
  • Charles Schwab's PRA Health Sciences, Inc. position peaked at $57.1M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.